Insulin resistance in skeletal muscle and liver may play a primary role in
the development of type 2 diabetes mellitus, and the mechanism by which ins
ulin resistance occurs may be related to alterations in fat metabolism. Tra
nsgenic mice with muscle- and liver-specific overexpression of lipoprotein
lipase were studied during a 2-h hyperinsulinemic-euglycemic clamp to deter
mine the effect of tissue-specific increase in fat on insulin action and si
gnaling. Muscle-lipoprotein lipase mice had a 3-fold increase in muscle tri
glyceride content and were insulin resistant because of decreases in insuli
n-stimulated glucose uptake in skeletal muscle and insulin activation of in
sulin receptor substrate-l-associated phosphatidylinositol 3-kinase activit
y. In contrast, liver-lipoprotein lipase mice had a 2-fold increase in live
r triglyceride content and were insulin resistant because of impaired abili
ty of insulin to suppress endogenous glucose production associated with def
ects in insulin activation of insulin receptor substrate-2-associated phosp
hatidylinositol 3-kinase activity. These defects in insulin action and sign
aling were associated with increases in intracellular fatty acid-derived me
tabolites (i.e.. diacylglycerol, fatty acyl CoA, ceramides). Our findings s
uggest a direct and causative relationship between the accumulation of intr
acellular fatty acid-derived metabolites and insulin resistance mediated vi
a alterations in the insulin signaling pathway, independent of circulating
adipocyte-derived hormones.